Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, B-Cell 2Neoplasms 1Motor Activity 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma 1Leukemia 1Dementia 1Cognitive Dysfunction 1Alzheimer Disease 1

Interventions

Methods 2Electroencephalography 2mazdutide 1fasudil 1blueberry extract 1Walking 1Tablets 1Standard of Care 1Rehabilitation, Vocational 1Referral and Consultation 1Hormones 1Exercise 1Employment, Supported 1Drug Delivery Systems 1Control Groups 1Accidental Falls 17-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Tablets × Lymphoid × Clear all
NCT04942184 2022-11-01

STRATEGIES to Improve Memory in Alzheimer's Disease

Boston University

Phase NA Withdrawn
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡